News related to Folotyn (Pralatrexate) and/or conditions it is approved for
Researchers Discover Master Regulator That Drives Majority Of Lymphoma
Source: Health News from Medical News Today [2013.05.17]
New Findings Show Inhibiting Powerful Protein with New Agents May Supply Broad Benefit for Lymphoma Patients A soon-to-be-tested class of drug inhibitors were predicted to help a limited number of patients with B-cell lymphomas with mutations affecting the EZH2 protein. However, a research team, led by investigators at Weill Cornell Medical College, now report that these agents may, in fact, help a much broader cross section of lymphoma patients...
Inhibiting Powerful Protein With New Agents May Supply Broad Benefit For Lymphoma Patients
Source: Genetics News From Medical News Today [2013.05.15]
A soon-to-be-tested class of drug inhibitors were predicted to help a limited number of patients with B-cell lymphomas with mutations affecting the EZH2 protein. However, a research team, led by investigators at Weill Cornell Medical College, now report that these agents may, in fact, help a much broader cross section of lymphoma patients...
The Search For Therapeutic Synergy In Primary Effusion Lymphoma
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2013.05.03]
Primary effusion lymphoma (PEL) is a rare, fatal form of aggressive B-cell lymphoma caused by Kaposi's sarcoma-associated herpesvirus (KSHV). The disease most commonly occurs in immunocompromised patients, such as those with HIV and the elderly. Because current treatment options are not effective, there is a great need for new PEL therapies...
New Strategy Helps Young Lymphoma Patients Avoid Radiation Treatment
Source: MedicineNet Leukemia Specialty [2013.04.11]
Title: New Strategy Helps Young Lymphoma Patients Avoid Radiation Treatment
Category: Health News
Created: 4/10/2013 6:35:00 PM
Last Editorial Review: 4/11/2013 12:00:00 AM
Melanoma Odds Doubled for Transplant, Lymphoma Patients: Study
Source: MedicineNet Hodgkins Disease Specialty [2012.10.11]
Title: Melanoma Odds Doubled for Transplant, Lymphoma Patients: Study
Category: Health News
Created: 10/10/2012 2:05:00 PM
Last Editorial Review: 10/11/2012 12:00:00 AM
Limited Radiation May Help Some Kids With Lymphoma
Source: MedicineNet Hodgkins Disease Specialty [2012.06.27]
Title: Limited Radiation May Help Some Kids With Lymphoma
Category: Health News
Created: 6/26/2012 6:05:00 PM
Last Editorial Review: 6/27/2012 12:00:00 AM
'Rediscovered' Lymphoma Drug Helps Double Survival: Study
Source: MedicineNet Non-Hodgkins Lymphomas Specialty [2012.06.04]
Title: 'Rediscovered' Lymphoma Drug Helps Double Survival: Study
Category: Health News
Created: 6/3/2012 10:05:00 AM
Last Editorial Review: 6/4/2012 12:00:00 AM
More Aggressive Chemo May Help Younger Lymphoma Patients: Study
Source: MedicineNet Neutropenia Specialty [2011.11.28]
Title: More Aggressive Chemo May Help Younger Lymphoma Patients: Study
Category: Health News
Created: 11/24/2011 8:05:00 PM
Last Editorial Review: 11/28/2011 12:00:00 AM
Non-Hodgkin's Lymphoma
Source: MedicineNet Biological Therapy Specialty [2011.09.08]
Title: Non-Hodgkin's Lymphoma
Category: Diseases and Conditions
Created: 12/31/1997 12:00:00 AM
Last Editorial Review: 9/8/2011 12:00:00 AM
Breakthrough test clearly distinguishes Burkitt lymphoma from DLBCL
Source: The Doctors Lounge - Oncology
A gene expression signature clearly distinguishes Burkitt lymphoma from DLBCL, a critical distinction in diagnosis.
Clinical Notes: Cause of Death Often False
Source: MedPage Today Emergency Medicine [2013.05.12]
(MedPage Today) -- Causes of death listed on official records have long been suspect, and a survey of medical residents in New York City found good reason for that. Also this week: a promising lymphoma drug fails.
|
